Physician profile
Gilbert Witte
NPI 1598764730
$2,639.77
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $604 · 2021: $938.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $964.34 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $595.78 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.88 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $245.44 | 2019-2021 | |
| Grifols USA, LLC | $128.94 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $97.32 | 2019-2021 | |
| Genzyme Corporation | $52.75 | 2019 | |
| Advanced Respiratory, INC | $31.97 | 2021 | |
| Insmed, INC. | $26.65 | 2021 | |
| Circassia INC. | $26.06 | 2019 | |
| Mylan Specialty L.P. | $19.23 | 2020 | |
| United Therapeutics Corporation | $16.07 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.47 | 2021 | |
| Philips North America LLC | $15.12 | 2020 | |
| Optinose US, INC. | $14.63 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valeritas, INC. | $13.15 | 2019 | |
| Medtronic Minimed, INC. | $12.33 | 2020 | |
| Mallinckrodt Hospital Products INC. | $11.64 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Witte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.